Institutional Council
This Council includes representatives from biopharmaceutical and medical device companies and service providers.
-
Special Interest Groups
- Biosimilars
- Clinical Outcome Assessment
- Digital Health
- Health Preference Research
- Medical Devices and Diagnostics
-
Medication Adherence and Persistence
-
Nutrition Economics
- Oncology
- Open Source Models
- Patient-Centered
- Precision Medicine and Advanced Therapies
- Rare Disease
- Real-World Evidence (RWE)
- Statistical Methods in HEOR
-
Task Forces
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) II
- Joint HTAi - ISPOR Deliberative Processes for HTA
- Machine Learning Methods in HEOR
-
Measurement Comparability Between Modes of Administration of PROMs
- Measuring Patient Preferences for Decision Making
- Performance Outcome (PerfO) Assessments
- Systematic Reviews with Cost and Cost-Effectiveness Outcomes
- Joint ISPE-ISPOR Special Task Force
- Councils & Roundtables
- Global Groups
- Students
-
New Professionals
-
Professional Development Resources
- What is the Impact of GDPR on the HEOR Community
- Good Practices for HTA - What is out there and how do I use it
- ISPOR & AACP Joint Webinar – “Tips for Securing a Post-Doctoral Fellowship”
- You Are Creative: Research is the First Step
- AMCP eDossier System @ FormularyDecisions.com Demo and Practical Application
- Good Practices for a Successful Job Search
- Leveraging The Power Of LinkedIn
- Internships & Fellowships: Career Opportunities for the Future
- My Career Path
- Career Advice Across the Globe
- "My ISPOR Story" - Zeba Khan
- "My ISPOR Story" - Lou Garrison
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 1
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 2
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 3
-
Professional Development Resources
Institutional Council Membership
The Institutional Council’s membership includes representatives from pharmaceutical, biotech and medical device companies and service providers (such as research and data analytic groups). The heterogeneous mix of this group provides a balanced environment for engaging scientific discussion and collaboration that includes diverse topics such as addressing the challenges of value and affordability in healthcare and expanding the use of real-world evidence in healthcare decision making. The Council’s purpose has always been to support and promote ISPOR’s mission as a professional and educational society.
Institutional Council members receive a unique set of benefits and privileges that provide access and visibility within the global HEOR community.
Gain Visibility
- Interact and collaborate with industry peers and key stakeholder groups
- Foster payer-industry collaboration
- Promote awareness of Council news and events
Network with Leaders
- Engage in collaborative environments for networking and scientific discussion
- Collaborate with ISPOR member groups and leadership
Bundled Benefits
- Discounted individual memberships
- Group meeting registrations
- Complimentary job postings in ISPOR’s HEOR Career Center
Institutional Council Fact Sheet
Download the Institutional Council Fact Sheet to learn more about the benefits of becoming a council member.
Mission
The ISPOR Institutional Council supports the mission of ISPOR as a scientific and educational society. The purpose of the Council is to proactively:
Promote the development of the fields of health economics and outcomes research globally
Promote the informed application and communication of health economics and outcomes research results in healthcare decision making
Promote enhancement of the quality of research by institutional members
Promote, support, and actively contribute to ISPOR as a premier scientific and professional society
Act as an advisory body to the ISPOR board, providing a forward-looking perspective
The Institutional Council is an official entity within ISPOR and will not publicly take positions outside of ISPOR or use ISPOR’s name, except with the explicit consent of the ISPOR Board
What We Do
Each year the Council undertakes specific projects to support the goals and objectives of ISPOR, while remaining true to the Council’s own objectives and purpose. An ongoing task of the Council is to identify emerging topics for special issues of Value in Health, ISPOR's international, indexed journal. Recent topics include: Personalized Medicine and the Role of Health Economics and Outcomes Research: Applications, Emerging Trends, and Future Research, and Health Technology Assessment in Evidence-Based Healthcare Reimbursement Decisions Around the World: Lessons Learned. The Council also works to identify scientific issues warranting a dedicated working group, such as the Comparative Effectiveness Research and Personalized Medicine Working Groups. Updates on Council’s activities are published in Value & Outcomes Spotlight, the Society's bimonthly publication for the global HEOR community.